- Home
- SCOR vs INKT Comparison
SCOR vs INKT Comparison
Compare SCOR & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- INKT
- Stock Information
- Founded
- SCOR 1999
- INKT 2017
- Country
- SCOR United States
- INKT United States
- Employees
- SCOR N/A
- INKT N/A
- Industry
- SCOR Business Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- SCOR Consumer Discretionary
- INKT Health Care
- Exchange
- SCOR Nasdaq
- INKT Nasdaq
- Market Cap
- SCOR 27.2M
- INKT 28.5M
- IPO Year
- SCOR 2007
- INKT 2021
- Fundamental
- Price
- SCOR $7.88
- INKT $0.77
- Analyst Decision
- SCOR Buy
- INKT Strong Buy
- Analyst Count
- SCOR 3
- INKT 1
- Target Price
- SCOR $12.83
- INKT $9.00
- AVG Volume (30 Days)
- SCOR 36.0K
- INKT 31.2K
- Earning Date
- SCOR 11-12-2024
- INKT 11-14-2024
- Dividend Yield
- SCOR N/A
- INKT N/A
- EPS Growth
- SCOR N/A
- INKT N/A
- EPS
- SCOR N/A
- INKT N/A
- Revenue
- SCOR $356,212,000.00
- INKT N/A
- Revenue This Year
- SCOR N/A
- INKT N/A
- Revenue Next Year
- SCOR $3.32
- INKT N/A
- P/E Ratio
- SCOR N/A
- INKT N/A
- Revenue Growth
- SCOR N/A
- INKT N/A
- 52 Week Low
- SCOR $4.89
- INKT $0.57
- 52 Week High
- SCOR $20.97
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- SCOR 69.09
- INKT 59.60
- Support Level
- SCOR $5.16
- INKT $0.74
- Resistance Level
- SCOR $6.22
- INKT $0.75
- Average True Range (ATR)
- SCOR 0.75
- INKT 0.04
- MACD
- SCOR 0.26
- INKT 0.01
- Stochastic Oscillator
- SCOR 72.93
- INKT 77.15
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.